Re: NFK meeting
|
8
|
Resverlogix Corp.
|
Feb 19, 2020 11:50PM
|
Re: As Pfizer charges ahead....
|
8
|
Resverlogix Corp.
|
Sep 11, 2021 01:32AM
|
Re: The runway is clear....
|
8
|
Resverlogix Corp.
|
Dec 06, 2018 01:05PM
|
Merry Christmas/Happy Holidays
|
8
|
Resverlogix Corp.
|
Dec 24, 2021 04:56PM
|
Merry Christmas to all
|
8
|
Resverlogix Corp.
|
Dec 24, 2022 01:59PM
|
RVX on local Calgary CTV at 5 and 6pm on 11 March
|
8
|
Resverlogix Corp.
|
Mar 12, 2021 10:06AM
|
Re: Why such little intrest, so close to the finis
|
8
|
Resverlogix Corp.
|
Nov 16, 2018 11:50PM
|
Re: Market Cap Context
|
8
|
Resverlogix Corp.
|
Jul 04, 2019 06:39PM
|
Re: Numerous Independent Groups Presented Data that Supports Apabetalone's Potential Cardio Benefits at Euro Society of Cardiology Congress 2024
|
8
|
Resverlogix Corp.
|
Sep 03, 2024 12:19PM
|
Re: so we are clear ,is there anything they can say or any possible way that this new info presented at the AHA
|
8
|
Resverlogix Corp.
|
Oct 01, 2019 03:22PM
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
8
|
Resverlogix Corp.
|
Jun 13, 2020 12:27PM
|
Re: Shawn lu RSU and option cancelled
|
8
|
Resverlogix Corp.
|
Apr 05, 2020 12:08PM
|
Re: Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N
|
8
|
Zenith Epigenetics
|
Feb 29, 2024 02:48PM
|
Re: When to expect the 250th Event
|
8
|
Resverlogix Corp.
|
Feb 26, 2019 03:27PM
|
Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
|
8
|
Resverlogix Corp.
|
Nov 02, 2020 06:23PM
|
Re: Ground Hog Day
|
9
|
Resverlogix Corp.
|
Sep 18, 2020 12:46PM
|
Momentum Players and Agoracom.com’s Rules
|
9
|
Resverlogix Corp.
|
Dec 18, 2021 02:18PM
|
Re: Tundup's message
|
9
|
Resverlogix Corp.
|
Apr 13, 2019 08:34PM
|
Re: Maybe its more about the who than the what....
|
9
|
Resverlogix Corp.
|
Aug 03, 2018 11:24AM
|
Re: Is the message really getting out there
|
9
|
Resverlogix Corp.
|
Mar 28, 2018 02:31PM
|